fluorodeoxyglucose f18 has been researched along with Chondrosteoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, M; Arora, A; Parasar, DS; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
| Chang, SS; Fawwaz, R; Lee, FY; Parisien, MV; Yu, J | 1 |
| Feldman, F; Parisien, M; Saxena, C; Van Heertum, R | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Chondrosteoma
| Article | Year |
|---|---|
Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Exostoses; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Pelvic Pain; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Topics: Bone Neoplasms; Cartilage Diseases; Chondroma; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Osteochondroma; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
18FDG-PET applications for cartilage neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cartilage Diseases; Child; Chondroma; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |